Małgorzata Leyk

2.7k total citations · 1 hit paper
8 papers, 2.0k citations indexed

About

Małgorzata Leyk is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Małgorzata Leyk has authored 8 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Pharmacology. Recurrent topics in Małgorzata Leyk's work include Metabolomics and Mass Spectrometry Studies (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Małgorzata Leyk is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Małgorzata Leyk collaborates with scholars based in United States, United Kingdom and Poland. Małgorzata Leyk's co-authors include Krzysztof Selmaj, Chris H. Polman, Ernst‐Wilhelm Radue, Peter A. Calabresi, Lixin Zhang-Auberson, P Burtin, Ludwig Kappos, Catherine Agoropoulou, Paul O’Connor and Reinhard Hohlfeld and has published in prestigious journals such as New England Journal of Medicine, Journal of Pharmacology and Experimental Therapeutics and European Respiratory Journal.

In The Last Decade

Małgorzata Leyk

8 papers receiving 2.0k citations

Hit Papers

A Placebo-Controlled Trial of Oral Fingolimod in Relapsin... 2010 2026 2015 2020 2010 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Małgorzata Leyk United States 5 1.4k 907 473 354 338 8 2.0k
Catherine Agoropoulou Switzerland 5 1.6k 1.1× 942 1.0× 536 1.1× 378 1.1× 352 1.0× 7 2.2k
Jeffrey A. Cohen United States 7 1.6k 1.2× 992 1.1× 580 1.2× 404 1.1× 328 1.0× 9 2.2k
Ana de Vera Switzerland 11 1.6k 1.1× 1.0k 1.1× 535 1.1× 403 1.1× 454 1.3× 17 2.3k
Lixin Zhang-Auberson Switzerland 10 2.0k 1.4× 1.3k 1.4× 699 1.5× 483 1.4× 423 1.3× 13 2.7k
Shreeram Aradhye United States 11 1.5k 1.1× 1.8k 2.0× 482 1.0× 443 1.3× 589 1.7× 22 3.3k
Kartik Raghupathi United States 9 1.1k 0.8× 399 0.4× 371 0.8× 417 1.2× 484 1.4× 22 2.0k
Mariko Kita United States 16 1.1k 0.8× 386 0.4× 420 0.9× 415 1.2× 480 1.4× 31 1.9k
Mark Novas United States 8 1.1k 0.8× 317 0.3× 327 0.7× 424 1.2× 309 0.9× 24 1.5k
John N. Whitaker United States 17 696 0.5× 514 0.6× 410 0.9× 199 0.6× 418 1.2× 44 1.7k
Emmanuelle Le Page France 18 1.5k 1.1× 201 0.2× 633 1.3× 551 1.6× 355 1.1× 52 1.8k

Countries citing papers authored by Małgorzata Leyk

Since Specialization
Citations

This map shows the geographic impact of Małgorzata Leyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Małgorzata Leyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Małgorzata Leyk more than expected).

Fields of papers citing papers by Małgorzata Leyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Małgorzata Leyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Małgorzata Leyk. The network helps show where Małgorzata Leyk may publish in the future.

Co-authorship network of co-authors of Małgorzata Leyk

This figure shows the co-authorship network connecting the top 25 collaborators of Małgorzata Leyk. A scholar is included among the top collaborators of Małgorzata Leyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Małgorzata Leyk. Małgorzata Leyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Curigliano, Giuseppe, M.M. Jimenez, Tomokazu Shimizu, et al.. (2024). A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies. ESMO Open. 9(8). 103643–103643. 7 indexed citations
2.
Kappos, Ludwig, Ernst‐Wilhelm Radue, Paul O’Connor, et al.. (2010). A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis. New England Journal of Medicine. 362(5). 387–401. 1960 indexed citations breakdown →
3.
Chan, John, Małgorzata Leyk, Brian M. Frier, & Meng H. Tan. (2009). Relationship between HbA1c and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metformin. Diabetes/Metabolism Research and Reviews. 25(3). 224–231. 11 indexed citations
4.
Jensen, Robert L., et al.. (2009). Quality control ofDL,COinstruments in global clinical trials. European Respiratory Journal. 33(4). 828–834. 13 indexed citations
5.
Bergenstal, Richard M., Nick Freemantle, Małgorzata Leyk, et al.. (2009). Does Availability of AIR Insulin Increase Insulin Use and Improve Glycemic Control in Patients with Type 2 Diabetes?. Diabetes Technology & Therapeutics. 11(s2). S–45. 4 indexed citations
6.
Williams, Eric T., et al.. (2007). The chimpanzee cytochrome P450 3A subfamily: Is our closest related species really that similar?. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 2(2). 91–100. 3 indexed citations
7.
Leyk, Małgorzata, Danh V. Nguyen, Edward R. Dougherty, et al.. (2005). Comparing Automatic and Manual Image Processing in FLARE Assay Analysis for Colon Carcinogenesis. Statistical Applications in Genetics and Molecular Biology. 4(1). Article5–Article5. 1 indexed citations
8.
Williams, Eric T., Małgorzata Leyk, Steven Wrighton, et al.. (2004). Estrogen Regulation of the Cytochrome P450 3A Subfamily in Humans. Journal of Pharmacology and Experimental Therapeutics. 311(2). 728–735. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026